Literature DB >> 29085973

The cathepsin B inhibitor z-FA-CMK induces cell death in leukemic T cells via oxidative stress.

K Y Liow1, Sek C Chow2.   

Abstract

The cathepsin B inhibitor benzyloxycarbonyl-phenylalanine-alanine-chloromethyl ketone (z-FA-CMK) was recently found to induce apoptosis at low concentrations in Jurkat T cells, while at higher concentrations, the cells die of necrosis. In the present study, we showed that z-FA-CMK readily depletes intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) generation. The toxicity of z-FA-CMK in Jurkat T cells was completely abrogated by N-acetylcysteine (NAC), suggesting that the toxicity mediated by z-FA-CMK is due to oxidative stress. We found that L-buthionine sulfoximine (BSO) which depletes intracellular GSH through the inhibition of GSH biosynthesis in Jurkat T cells did not promote ROS increase or induce cell death. However, NAC was still able to block z-FA-CMK toxicity in Jurkat T cells in the presence of BSO, indicating that the protective effect of NAC does not involve GSH biosynthesis. This is further corroborated by the protective effect of the non-metabolically active D-cysteine on z-FA-CMK toxicity. Furthermore, in BSO-treated cells, z-FA-CMK-induced ROS increased which remains unchanged, suggesting that the depletion of GSH and increase in ROS generation mediated by z-FA-CMK may be two separate events. Collectively, our results demonstrated that z-FA-CMK toxicity is mediated by oxidative stress through the increase in ROS generation.

Entities:  

Keywords:  D-Cysteine; Glutathione; L-Buthionine sulfoximine; L-Cysteine; N-Acetylcysteine; Oxidative stress; Reactive oxygen species; T cells; Z-FA-CMK

Mesh:

Substances:

Year:  2017        PMID: 29085973     DOI: 10.1007/s00210-017-1436-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  68 in total

1.  Direct evidence for the presence of histidine in the active center of chymotrypsin.

Authors:  G SCHOELLMANN; E SHAW
Journal:  Biochemistry       Date:  1963 Mar-Apr       Impact factor: 3.162

2.  Mitochondrial damage induced by conditions of oxidative stress.

Authors:  A J Kowaltowski; A E Vercesi
Journal:  Free Radic Biol Med       Date:  1999-02       Impact factor: 7.376

3.  Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.

Authors:  O W Griffith
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

4.  Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones.

Authors:  J C Powers; B F Gupton; A D Harley; N Nishino; R J Whitley
Journal:  Biochim Biophys Acta       Date:  1977-11-23

5.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

6.  The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis.

Authors:  Fengjiao Zhang; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2010-12-06       Impact factor: 4.849

7.  N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.

Authors:  Kyung-Ho Ha; Mi-Sun Byun; Jin Choi; Jaeho Jeong; Kong-Joo Lee; Dae-Myung Jue
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

8.  Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes.

Authors:  M Weis; J Schlegel; G E Kass; T H Holmström; I Peters; J Eriksson; S Orrenius; S C Chow
Journal:  Exp Cell Res       Date:  1995-08       Impact factor: 3.905

9.  EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.

Authors:  Hui-Lung Sun; An-Chi Tsai; Shiow-Lin Pan; Qingqing Ding; Hirohito Yamaguchi; Chun-Nan Lin; Mien-Chie Hung; Che-Ming Teng
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

10.  Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin B.

Authors:  D Rasnick
Journal:  Anal Biochem       Date:  1985-09       Impact factor: 3.365

View more
  2 in total

Review 1.  Cathepsin B: A sellsword of cancer progression.

Authors:  Olja Mijanović; Ana Branković; Alexander N Panin; Solomiia Savchuk; Peter Timashev; Ilya Ulasov; Maciej S Lesniak
Journal:  Cancer Lett       Date:  2019-02-20       Impact factor: 8.679

2.  Cathepsin B aggravated doxorubicin‑induced myocardial injury via NF‑κB signalling.

Authors:  Chen Liu; Zhulan Cai; Tongtong Hu; Qi Yao; Lijun Zhang
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.